Hjem
  • E-postsverre.sandberg@uib.no
  • Besøksadresse
    Alrek helseklynge, blokk D, Årstadveien 17
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2018). Within-subject and between-subject biological variation estimates of 21 hematological parameters in 30 healthy subjects. Clinical Chemistry and Laboratory Medicine. 1309-1318.
  • Vis forfatter(e) (2018). The EuBIVAS: Within- and between-subject biological variation data for electrolytes, lipids, urea, uric acid, total protein, total bilirubin, direct bilirubin, and glucose. Clinical Chemistry. 1380-1393.
  • Vis forfatter(e) (2018). Hjemmetjenesten driver omfattende laboratorievirksomhet. Sykepleien Forskning. 1-15.
  • Vis forfatter(e) (2018). Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014. Scandinavian Journal of Primary Health Care. 170-179.
  • Vis forfatter(e) (2017). Warfarin monitoring in nursing homes assessed by case histories. Do recommendations and electronic alerts affect judgements? Scandinavian Journal of Primary Health Care. 299-306.
  • Vis forfatter(e) (2017). Type 2 diabetes in general practice in Norway 2005-2015: moderate improvements in risk factor control, but still major gaps in complication screening. BMJ Open Diabetes Research & Care. 11 sider.
  • Vis forfatter(e) (2017). The EuBIVAS project: within- and between-subject biological variation data for serum creatinine using enzymatic and alkaline picrate methods and implications for monitoring. Clinical Chemistry. 1527-1536.
  • Vis forfatter(e) (2017). Intensive educational efforts combined with external quality assessment improve the preanalytical phase in general practitioner offices and nursing homes. Clinical Chemistry and Laboratory Medicine. 1857-1864.
  • Vis forfatter(e) (2017). Glycemic control and complications in patients with type 1 diabetes – a registry-based longitudinal study of adolescents and young adults. Pediatric Diabetes. 188-195.
  • Vis forfatter(e) (2017). Estimates of within-subject biological variation of protein c, antithrombin, protein s free, protein s activity, and activated protein c resistance in pregnant women. Clinical Chemistry. 898-907.
  • Vis forfatter(e) (2017). Biological variation: Evaluation of methods for constructing confidence intervals for estimates of within-person biological variation for different distributions of the within-person effect. Clinica Chimica Acta. 166-173.
  • Vis forfatter(e) (2017). Biological variation estimates obtained from 91 healthy study participants for 9 enzymes in serum. Clinical Chemistry. 1141-1150.
  • Vis forfatter(e) (2017). Acute hepatic porphyria and cancer risk: a nationwide cohort study. Journal of Internal Medicine. 229-240.
  • Vis forfatter(e) (2017). A pragmatic approach to sample acceptance and rejection. Clinical Biochemistry. 605-611.
  • Vis forfatter(e) (2016). The variation in high sensitive cardiac troponin concentration during haemodialysis treatment is not similar to the biological variation observed in stable end stage renal disease patients. Scandinavian Journal of Clinical and Laboratory Investigation. 645-652.
  • Vis forfatter(e) (2016). The importance of reagent lot registration in external quality assurance/proficiency testing schemes. Clinical Chemistry. 708-715.
  • Vis forfatter(e) (2016). Sample collections from healthy volunteers for biological variation estimates' update: A new project undertaken by the Working Group on Biological Variation established by the European Federation of Clinical Chemistry and Laboratory Medicine. Clinical Chemistry and Laboratory Medicine. 1599-1608.
  • Vis forfatter(e) (2016). Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thrombosis Research. 1-7.
  • Vis forfatter(e) (2016). Illness perception and psychological distress in persons with porphyria cutanea tarda. Acta Dermato-Venereologica. 674-678.
  • Vis forfatter(e) (2016). Effect of participating in a quality improvement system over time for point-of-care c-reactive protein, glucose, and hemoglobin testing. Clinical Chemistry. 1474-1481.
  • Vis forfatter(e) (2016). Biological variation: The effect of different distributions on estimated within-person variation and reference change values. Clinical Chemistry. 725-736.
  • Vis forfatter(e) (2015). Setting analytical performance specifications based on outcome studies - Is it possible? Clinical Chemistry and Laboratory Medicine. 841-848.
  • Vis forfatter(e) (2015). Proposal for the modification of the conventional model for establishing performance specifications. Clinical Chemistry and Laboratory Medicine. 925-937.
  • Vis forfatter(e) (2015). Point-of-care urine albumin in general practice offices: Effect of participation in an external quality assurance scheme. Clinical Chemistry and Laboratory Medicine. 45-51.
  • Vis forfatter(e) (2015). Feasibility of using self-reported patient data in a national diabetes register. BMC Health Services Research. 1-7.
  • Vis forfatter(e) (2015). Egenkontroll av warfarinbehandling. Tidsskrift for Den norske legeforening. 849-853.
  • Vis forfatter(e) (2015). Benchmarking by HbA1c in a national diabetes quality register - does measurement bias matter? Clinical Chemistry and Laboratory Medicine. 1433-1439.
  • Vis forfatter(e) (2015). Analytical performance specifications based on how clinicians use laboratory tests. Experiences from a post-analytical external quality assessment programme. Clinical Chemistry and Laboratory Medicine. 857-862.
  • Vis forfatter(e) (2015). An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. Clinical Chemistry and Laboratory Medicine. 1593-1603.
  • Vis forfatter(e) (2015). A skin disease, a blood disease or something in between? : an exploratory focus group study of patients' experiences with porphyria cutanea tarda. British Journal of Dermatology. 223-229.
  • Vis forfatter(e) (2015). A checklist for critical appraisal of studies of biological variation. Clinical Chemistry and Laboratory Medicine. 879-885.
  • Vis forfatter(e) (2014). Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clinical Chemistry. 838-847.
  • Vis forfatter(e) (2014). The influence of coagulation factors on the in-treatment biological variation of international normalized ratio for patients on warfarin. Scandinavian Journal of Clinical and Laboratory Investigation. 470-476.
  • Vis forfatter(e) (2014). Porfyrisykdommer i Norge. Tidsskrift for Den norske legeforening. 831-835.
  • Vis forfatter(e) (2014). Nursing home patients with diabetes: Prevalence, drug treatment and glycemic control. Diabetes Research and Clinical Practice. 102-109.
  • Vis forfatter(e) (2014). How to achieve harmonisation of laboratory testing -The complete picture. Clinica Chimica Acta. 8-14.
  • Vis forfatter(e) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Vis forfatter(e) (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta. 49-57.
  • Vis forfatter(e) (2014). Albumin adsorption onto surfaces of urine collection and analysis containers. Clinica Chimica Acta. 40-45.
  • Vis forfatter(e) (2013). The Norwegian Diabetes Register for Adults –an overview of the first years. Norsk Epidemiologi. 29-34.
  • Vis forfatter(e) (2013). Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue. Annales de Biologie Clinique. 707-716.
  • Vis forfatter(e) (2013). External quality assessment of point-of-care methods: model for combined assessment of method bias and single-participant performance by the use of native patient samples and noncommutable control materials. Clinical Chemistry. 363-371.
  • Vis forfatter(e) (2013). Diagnosing Diabetes Mellitus: Performance of Hemoglobin A(1c) Point-of-Care Instruments in General Practice Offices. Clinical Chemistry. 1790-1801.
  • Vis forfatter(e) (2013). Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria. Bioscience Reports. 617-U203.
  • Vis forfatter(e) (2013). Behandlingen av type 1-diabetes i spesialisthelsetjenesten – data fra Norsk diabetesregister for voksne. Tidsskrift for Den norske legeforening. 2257-2261.
  • Vis forfatter(e) (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and gamma-glutamyl transferase. Clinical Chemistry and Laboratory Medicine. 1997-2007.
  • Vis forfatter(e) (2012). Regional differences in sales of glucometer strips and antidiabetics. Tidsskrift for Den norske legeforening. 1453-1456.
  • Vis forfatter(e) (2012). Preanalytical quality improvement: in quality we trust. Clinical Chemistry and Laboratory Medicine.
  • Vis forfatter(e) (2012). Interpretation and management of INR results: A case history based survey in 13 countries. Thrombosis Research. 309-315.
  • Vis forfatter(e) (2012). Increased yet iron-restricted erythropoiesis in postpartum mothers. Annals of Hematology. 1435-1441.
  • Vis forfatter(e) (2012). How do laboratory specialists advise clinicians concerning the use and interpretation of renal tests? Scandinavian Journal of Clinical and Laboratory Investigation. 143-151.
  • Vis forfatter(e) (2012). External quality assessment of point-of-care International Normalized Ratio (INR) testing in Europe. Clinical Chemistry and Laboratory Medicine. 81-88.
  • Vis forfatter(e) (2012). Establishing a network of specialist Porphyria centres - effects on diagnostic activities and services. Orphanet Journal of Rare Diseases. 9 sider.
  • Vis forfatter(e) (2012). Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments. Clinical Chemistry and Laboratory Medicine. 1611-1620.
  • Vis forfatter(e) (2012). Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples, and number of individuals. Clinical Chemistry. 1306-1313.
  • Vis forfatter(e) (2012). A model for calculating the within-subject biological variation and likelihood ratios for analytes with a time-dependent change in concentrations; exemplified with the use of D-dimer in suspected venous thromboembolism in healthy pregnant women. Annals of Clinical Biochemistry. 561-569.
  • Vis forfatter(e) (2011). Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clinical Chemistry and Laboratory Medicine. 1501-1507.
  • Vis forfatter(e) (2011). Standardisert hemoglobin A1C til diagnostisk bruk? Tidsskrift for Den norske legeforening. 565-6.
  • Vis forfatter(e) (2011). Quality assurance of laboratory work and clinical use of laboratory tests in general practice in Norway: A survey. Scandinavian Journal of Primary Health Care. 171-175.
  • Vis forfatter(e) (2011). Preanalytical quality improvement: from dream to reality. Clinical Chemistry and Laboratory Medicine. 1113-1126.
  • Vis forfatter(e) (2011). Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care. Clinica Chimica Acta. 1138-1142.
  • Vis forfatter(e) (2011). European specialist porphyria laboratories: diagnostic strategies, analytical quality, clinical interpretation, and reporting as assessed by an external quality assurance program. Clinical Chemistry. 1514-1523.
  • Vis forfatter(e) (2011). Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems. Diabetes Technology & Therapeutics. 883-892.
  • Vis forfatter(e) (2011). Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus? Clinical Chemistry and Laboratory Medicine. 637-640.
  • Vis forfatter(e) (2010). Usefulness of factor V Leiden mutation testing in clinical practice. European Journal of Human Genetics. 862-866.
  • Vis forfatter(e) (2010). The Prevalence of Self-Monitoring of Blood Glucose and Costs of Glucometer Strips in a Nationwide Cohort. Diabetes Technology & Therapeutics. 701-705.
  • Vis forfatter(e) (2010). Quality assessment of patients’ self-monitoring of blood glucose in community pharmacies. Pharmacy Practice. 62-69.
  • Vis forfatter(e) (2010). Implementation of a method for glucose measurements in community pharmacies. International Journal of Pharmacy Practice (IJPP). 13-19.
  • Vis forfatter(e) (2010). Discrepancies in International Normalized Ratio Results between Instruments: A Model to Split the Variation into Subcomponents. Clinical Chemistry. 1618-1626.
  • Vis forfatter(e) (2010). Diagnosing microalbuminuria and consequences for the drug treatment of patients with type 2 diabetes: A European survey in primary care. Diabetes Research and Clinical Practice. 103-109.
  • Vis forfatter(e) (2009). Quality of Care for Patients With Type 2 Diabetes in Primary Care in Norway Is Improving Results of cross-sectional surveys of 33 general practices in 1995 and 2005. Diabetes Care. 81-83.
  • Vis forfatter(e) (2009). Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials. Thrombosis and Haemostasis. 593-600.
  • Vis forfatter(e) (2009). How to deal with semi-quantitative tests? Application of an ordinal scale model to measurements of urine glucose. Scandinavian Journal of Clinical and Laboratory Investigation. 662-U18.
  • Vis forfatter(e) (2009). Familial and sporadic porphyria cutanea tarda: characterization and diagnostic strategies. Clinical Chemistry. 795-803.
  • Vis forfatter(e) (2009). Familial and sporadic porphyria cutanea tarda: Characterization and diagnostic strategies. Clinical Chemistry. 795-803.
  • Vis forfatter(e) (2008). Standardized Evaluation of Nine Instruments for Self-Monitoring of Blood Glucose. Diabetes Technology & Therapeutics. 467-477.
  • Vis forfatter(e) (2008). Riktigere bruk av laboratorietjenester – økonomiske aspekter. Tidsskrift for Den norske legeforening. 814-817.
  • Vis forfatter(e) (2008). Riktigere bruk av laboratorietjenester – medisinske aspekter. Tidsskrift for Den norske legeforening. 810-813.
  • Vis forfatter(e) (2008). Postanalytical external quality assessment of urine albumin in primary health care: An international survey. Clinical Chemistry. 1630-1636.
  • Vis forfatter(e) (2008). Opinion Paper: 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). Clinical Chemistry and Laboratory Medicine. 157-164.
  • Vis forfatter(e) (2008). How to deal with dichotomous tests? Application of a rankit ordinal scale model with examples from the Nordic ordinal scale project on screening tests. Scandinavian Journal of Clinical and Laboratory Investigation. 298-311.
  • Vis forfatter(e) (2008). Diabetes care in Norwegian pharmacies: a descriptive study. Pharmacy World & Science (PWS). 191-198.
  • Vis forfatter(e) (2008). 'Likelihood-ratio' and 'odds' applied to monitoring of patients as a supplement to 'reference change value' (RCV). Clinical Chemistry and Laboratory Medicine. 157-164.
  • Vis forfatter(e) (2006). Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clinical Chemistry. 1311-1317.
  • Vis forfatter(e) (2006). Quality assessment of urine dip-slides in primary care. Tidsskrift for Den norske legeforening. 149-152.
  • Vis forfatter(e) (2006). Proficiency testing in analytical chemistry, microbiology and laboratory medicine - working group discussions on current status, problems and future directions. Accreditation and Quality Assurance. 446-450.
  • Vis forfatter(e) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry. 1871-1878.
  • Vis forfatter(e) (2006). Postanalytical external quality assessment of warfarin monitoring in primary healthcare. Clinical Chemistry.
  • Vis forfatter(e) (2006). External quality assessment of prothrombin time: The split-sample model compared with external quality assessment with commercial control material. Scandinavian Journal of Clinical and Laboratory Investigation. 337-349.
  • Vis forfatter(e) (2006). Estimation and application of biological variation of urinary delta-aminolevulinic acid and porphobilinogen in healthy individuals and in patients with acute intermittent porphyria. Clinical Chemistry. 650-656.
  • Vis forfatter(e) (2006). Estimation and Application of Biological Variation of Urinary δ-Aminolevulinic Acid and Porphobilinogen in Healthy Individuals and in Patients with Acute Intermittent Porphyria. Clinical Chemistry. 650-656.
  • Vis forfatter(e) (2005). Postanalytical external quality assessment of blood glucose and hemoglobin A(1c): An international survey. Clinical Chemistry. 1145-1153.
  • Vis forfatter(e) (2005). Porphyrias, a challenge for diagnostic assessment and treatment. Clinical Laboratory International. 6-8.
  • Vis forfatter(e) (2005). Between-lot variation in external quality assessment of glucose: Clinical importance and effect on participant performance evaluation. Clinical Chemistry. 1632-1636.
  • Vis forfatter(e) (2004). Urine analysis and decision-making on cystitis in general practice. Scandinavian Journal of Clinical and Laboratory Investigation. 729-736.
  • Vis forfatter(e) (2004). Prostrate-specific antigen and prostate cancer: General practitioners' and urologists' use of evidence-based information. Tidsskrift for Den norske legeforening. 2893-2895.
  • Vis forfatter(e) (2004). Evidence-based guidelines in laboratory medicine: Principles and methods. Clinical Chemistry. 806-818.
  • Vis forfatter(e) (2004). Basic model and preliminary results on a Nordfond project on measurements reported on an ordinal scale. Klinisk Biokemi i Norden. 21-26.
  • Vis forfatter(e) (2004). A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scandinavian Journal of Clinical and Laboratory Investigation. 385-398.
  • Vis forfatter(e) (2003). Human reticulocytes isolated from peripheral blood: maturation time and hemoglobin synthesis. Laboratory Hematology. 198-206.
  • Vis forfatter(e) (2003). Health technology assessment and implications for clinical practice: The case of prostate cancer screening. Scandinavian Journal of Clinical and Laboratory Investigation. 331-338.
  • Vis forfatter(e) (2003). Haplotype analysis of Norwegian and Swedish patients with acute intermittent porphyria (AIP): Extreme haplotype heterogeneity for the mutation R116W. Disease Markers. 41-46.
  • Vis forfatter(e) (2003). Evaluering av nye laboratorieanalyser. Tidsskrift for Den norske legeforening. 337-339.
  • Vis forfatter(e) (2003). Evaluation of new laboratory tests. Tidsskrift for Den norske legeforening. 377-379.
  • Vis forfatter(e) (2003). Er GUM skadelig - eller blot overflødig? Klinisk Biokemi i Norden. 27-32.
  • Vis forfatter(e) (2002). Instruments for self-monitoring of blood-glucose: comparison of testing quality achieved by patients and a technician. Clinical Chemistry. 994-1003.
  • Vis forfatter(e) (2001). Quality of rapid tests for determination of infectious mononucleosis. Tidsskrift for Den norske legeforening. 1793-1797.
  • Vis forfatter(e) (2001). Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clinical Chemistry. 67-73.
  • Vis forfatter(e) (2001). Models for combining random and systematic errors, assumptions and consequences for different models. Clinical Chemistry and Laboratory Medicine. 589-595.
  • Vis forfatter(e) (2001). Interpretation of hemaglobin A(1c)(HbA(1c)) values among diabetic patients: implications for quality specifications for HbA(1c). Clinical Chemistry. 1212-1217.
  • Vis forfatter(e) (2001). Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clinical Chemistry and Laboratory Medicine. 160-165.
  • Vis forfatter(e) (2001). External quality assessment of general practice laboratories: organizational issues and interpretation of feedback reports. Scandinavian Journal of Clinical and Laboratory Investigation. 103-110.
  • Vis forfatter(e) (2001). Analyse av protrombintid i primærhelsetjenesten. Tidsskrift for Den norske legeforening. 3435-3436.
  • Vis forfatter(e) (2001). Akutt intermitterende porfyri er en vanskelig diagnose - spesielt hos barn. Tidsskrift for Den norske legeforening. 2822-2825.
  • Vis forfatter(e) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Vis forfatter(e) (2000). Use and interpretation og HbA1c-testing in general practice. Implications for quality of care. Scandinavian Journal of Clinical and Laboratory Investigation. 349-356.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 4437-4448.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Tidsskrift for Den norske legeforening. 1754-1760.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av sår hals. Läkartidningen. 1754-1760.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Vis forfatter(e) (2000). Retningslinjer for diagnostikk og behandling av akutte vannlatingsplager hos kvinner. Tidsskrift for Den norske legeforening. 1748-1753.
  • Vis forfatter(e) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Vis forfatter(e) (2000). Porphyrins and Porphyrias. Review and special articles from the Nordic countries. (Spesialnummer). Scandinavian Journal of Clinical and Laboratory Investigation. 508-648.
  • Vis forfatter(e) (2000). Nodelling an estimation of measurement error. Statistics in Medicine. 146.
  • Vis forfatter(e) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Vis forfatter(e) (2000). Nivået på dokumentasjonen og styrken på anbefalingene i kliniske retningslinjer. Tidsskrift for Den norske legeforening. 1791-1795.
  • Vis forfatter(e) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241 sider.
  • Vis forfatter(e) (2000). Kan laboratoriesvaret få konsekvenser for pasienten? Tidsskrift for Den norske legeforening. 2241.
  • Vis forfatter(e) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Vis forfatter(e) (2000). Foster med hydrops hos kvinne fra Vietnam. Tidsskrift for Den norske legeforening. 1878-1881.
  • Vis forfatter(e) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Vis forfatter(e) (2000). Automated counting of white and red blood cells in the cerebrospinal fluid. Clinical and Laboratory Haematology. 203-210.
  • Vis forfatter(e) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Vis forfatter(e) (2000). A model for setting analytical quality specifications and design of control for measurements on the ordinal scale. Clinical Chemistry and Laboratory Medicine. 545-551.
  • Vis forfatter(e) (1999). The index of individuality is often a misinterpreted quantity characteristic. Clinical Chemistry and Laboratory Medicine. 655-661.
  • Vis forfatter(e) (1999). Skandinavisk utprøving av laboratorieutstyr for primærhelsetjenesten. Etablering av SKUP og igangsetting av de første evalueringene. Klinisk Biokemi i Norden. 56-60.
  • Vis forfatter(e) (1999). Quality specifications based upon objective analyses based upon clinical needs. Scandinavian Journal of Clinical and Laboratory Investigation.
  • Vis forfatter(e) (1999). Oppslagsbok i laboratoriemedisin. Tidsskrift for Den norske legeforening.
  • Vis forfatter(e) (1999). Measurement error and laboratory medicine. Statistics in Medicine.
  • Vis forfatter(e) (1999). External quality assurance of test requesting and test interpretations in general practice. A method for developing quality goals from clinicians' opinion and to implement guidelines. Labquality News. 13-14.
  • Vis forfatter(e) (1999). External quality assurance of test requesting and test interpretation. Accreditation and Quality Assurance. 414-415.
  • Vis forfatter(e) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Vis forfatter(e) (1999). Cobalamin deficiency in general practice. Assessment of the diagnostic utility and cost-benefit analysis of methylmalonic acid determination in relation to current diagnostic strategies. Clinical Chemistry. 189-198.
  • Vis forfatter(e) (1999). Circadian variations in human peripheral blood on days with and witout bone marrow sampling and relation to bone marroe cell proliferation. Biological rhythm research. 29-53.
  • Vis forfatter(e) (1999). Circadian variation in human peripheral blood on days with and without bone marrow sampling and relation to bone marrow proliferation. Biological rhythm research. 29-53.
  • Vis forfatter(e) (1999). Circadian Variations in Human Peripheral Blood on Days With and Without Bone Marrow Sampling and Relation to Bone Marrow Cell Proliferation. Biological rhythm research. 29-53.
  • Vis forfatter(e) (1999). Bruk og tolking av serum-kalsiumanalyse. Tidsskrift for Den norske legeforening. 3299.
  • Vis forfatter(e) (1998). Resultater fra NOKLUS' utsendelser 1993-97. Tidsskrift for Den norske legeforening. 1196-1200.
  • Vis forfatter(e) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Vis forfatter(e) (1997). Use and usefulnes of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Vis forfatter(e) (1997). Use and usefullness of laboratory handbooks. Scandinavian Journal of Clinical and Laboratory Investigation. 647-654.
  • Vis forfatter(e) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Vis forfatter(e) (1997). Systematic reviews of diagnostic tests - a new challenge for laboratory medicine. Scandinavian Journal of Clinical and Laboratory Investigation. 369-372.
  • Vis forfatter(e) (1997). Systematic reviewing in laboratory medicine. JIFCC. 154-155.
  • Vis forfatter(e) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5.
  • Vis forfatter(e) (1997). Systematic review of diagnostic tests. Nordic newsletter on evidence-based health care. 5-5.
  • Vis forfatter(e) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Vis forfatter(e) (1997). SKUP - Skandinavisk samarbeid om utprøving av laboratorieutstyr for primærhelsetjenesten. Klinisk Biokemi i Norden. 49-52.
  • Vis forfatter(e) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Vis forfatter(e) (1997). Etablering av referanseverdier. Bioingeniøren. 5-7.
  • Vis forfatter(e) (1996). Erythropoietic, protoporphyria: two populations of reticulocytes, with and without protoporphyrin. European Journal of Clinical Investigation. 270-8.
  • Vis forfatter(e) (1996). Analysekvalitet av hemoglobin og glukose i allmennpraksis. Tidsskrift for Den norske legeforening. 25-9.
  • Vis forfatter(e) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Vis forfatter(e) (1995). Circadian phase relationships between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-390.
  • Vis forfatter(e) (1995). Circadian phase relationship between peripheral blood variables and bone marrow proliferative activity in clinical health. In Vivo. 379-89.
Vitenskapelig foredrag
  • Vis forfatter(e) (2017). Type 2 diabetes in General Practice in Norway 2005-2014: Moderate improvements in risk Control but still major gaps in complication screening.
  • Vis forfatter(e) (2007). Control of patients' glucometers and SMBG technique in community pharmacies.
  • Vis forfatter(e) (2006). How to deal with qualitative tests? Principles.
  • Vis forfatter(e) (2004). Hvordan bruker legene urinstrimmelen til diagnostikk av UVI?
Sammendrag/abstract
  • Vis forfatter(e) (2014). POC testing instruments for diagnosing and monitoring diabetes in clinical settings. Biochemia Medica. S39-S40.
  • Vis forfatter(e) (2013). Searching for pharmacological chaperones aiding to stabilize hydroxymethylbilane synthase. The FEBS Journal. 298-298.
  • Vis forfatter(e) (2011). Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in minors. British Journal of Dermatology. 1133-1134.
  • Vis forfatter(e) (2011). POST-ANALYTICAL EXTERNAL QUALITY ASSESSMENT - A WAY TO ASSESS TEST REQUESTING AND INTERPRETATION. Clinical Chemistry and Laboratory Medicine. S111-S111.
  • Vis forfatter(e) (2011). Optimizing porphyria diagnostics with emphasis on pre-analytical, analytical and postanalytical aspects S. Sandberg on behalf of EPNET. British Journal of Dermatology. 1129-1129.
  • Vis forfatter(e) (2010). Characterization of the molecular basis of acute intermittent porphyria. The FEBS Journal. 76-76.
  • Vis forfatter(e) (2010). CHARACTERIZATION OF THE MOLECULAR BASIS OF ACUTE INTERMITTENT PORPHYRIA. The Journal of Inherited Metabolic Disease (JIMD). S177-S177.
  • Vis forfatter(e) (2005). External quality assessments of whole blood prothrombin time: Comparison of two methods. Clinica Chimica Acta.
  • Vis forfatter(e) (2005). Can we interpret laboratory results correctly? Clinica Chimica Acta.
  • Vis forfatter(e) (2005). Between lot variation in external quality assessment of glucose: Clinical importance and effect on the evaluation of participants' performance. Clinica Chimica Acta.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2022). Personalized reference intervals: from theory to practice. Critical reviews in clinical laboratory sciences.
  • Vis forfatter(e) (2022). Critical review and meta-analysis of biological variation estimates for tumor markers. Clinical Chemistry and Laboratory Medicine. 494-504.
  • Vis forfatter(e) (2022). Biological variation: recent development and future challenges. Clinical Chemistry and Laboratory Medicine.
  • Vis forfatter(e) (2021). The European Biological Variation Study (EuBIVAS): A summary report. Clinical Chemistry and Laboratory Medicine. 1-13.
  • Vis forfatter(e) (2021). Setting analytical performance specifications using HbA1c as a model measurand. Clinica Chimica Acta. 407-414.
  • Vis forfatter(e) (2021). Biological variation of cardiac troponins in health and disease: A systematic review and meta-analysis. Clinical Chemistry. 256-264.
  • Vis forfatter(e) (2021). Acute intermittent porphyria: An overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators. International Journal of Molecular Sciences. 25 sider.
  • Vis forfatter(e) (2020). Critical evaluation and meta-analysis of biological variation studies for glycosylated albumin, glucose and HbA<inf>1c</inf>. Advances in laboratory medicine.
  • Vis forfatter(e) (2020). Critical appraisal and meta-analysis of biological variation estimates for kidney related analytes. Clinical Chemistry and Laboratory Medicine. 1-10.
  • Vis forfatter(e) (2019). Systematic review of the biological variation data for diabetes related analytes. Clinica Chimica Acta. 61-67.
  • Vis forfatter(e) (2019). Systematic review and meta-analysis of within-subject and between-subject biological variation estimates of 20 haematological parameters. Clinical Chemistry and Laboratory Medicine. 25-32.
  • Vis forfatter(e) (2019). Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC). Clinica Chimica Acta. 467-475.
  • Vis forfatter(e) (2017). Essential aspects of external quality assurance for point-of-care testing. Biochemia Medica. 81-85.
  • Vis forfatter(e) (2017). Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference. Clinical Chemistry and Laboratory Medicine. 189-194.
  • Vis forfatter(e) (2014). How to conduct External Quality Assessment Schemes for the pre-analytical phase? Biochemia Medica. 114-122.
  • Vis forfatter(e) (2013). Glucose meters - fit for clinical purpose. Clinical Chemistry and Laboratory Medicine. 943-952.
  • Vis forfatter(e) (2012). Self-monitoring of blood glucose in patients with diabetes who do not use insulinuare guidelines evidence-based? Diabetic Medicine. 1226-1236.
  • Vis forfatter(e) (2010). Self-monitoring of blood glucose with a focus on analytical quality: an overview. Clinical Chemistry and Laboratory Medicine. 963-972.
  • Vis forfatter(e) (2009). Evaluation of prescription and interpretation of microalbuminuria by general practitioners. Annales de Biologie Clinique. 47-53.
  • Vis forfatter(e) (2009). Current Issues in Measurement and Reporting of Urinary Albumin Excretion. Clinical Chemistry. 24-38.

Se fullstendig oversikt over publikasjoner i CRIStin.